ANTI-IL-5 ANTIBODIES
Disclosed herein are fully human antibody molecules that immunospecifically bind to human IL-5. The antibody molecules can bind to human IL-5 with an equilibrium affinity constant (KD) of at least about 40 pM as determined by surface plasmon resonance. 本文公开了与人IL-5免疫特异性地结合的全人抗体分子。该抗体分子可以与人IL-5结合，按照通过...
Saved in:
| Main Authors | , , , , |
|---|---|
| Format | Patent |
| Language | Chinese English |
| Published |
20.09.2019
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Disclosed herein are fully human antibody molecules that immunospecifically bind to human IL-5. The antibody molecules can bind to human IL-5 with an equilibrium affinity constant (KD) of at least about 40 pM as determined by surface plasmon resonance.
本文公开了与人IL-5免疫特异性地结合的全人抗体分子。该抗体分子可以与人IL-5结合，按照通过表面等离子体共振测定的平衡亲和常数(K)为至少约40pM。 |
|---|---|
| AbstractList | Disclosed herein are fully human antibody molecules that immunospecifically bind to human IL-5. The antibody molecules can bind to human IL-5 with an equilibrium affinity constant (KD) of at least about 40 pM as determined by surface plasmon resonance.
本文公开了与人IL-5免疫特异性地结合的全人抗体分子。该抗体分子可以与人IL-5结合，按照通过表面等离子体共振测定的平衡亲和常数(K)为至少约40pM。 |
| Author | COOKSEY BRIDGET ANN LAINE DAVID JOSE SIMON DOYLE ANTHONY CLARKE ADAM LIDDAMENT MARK TERENCE |
| Author_xml | – fullname: LAINE DAVID JOSE SIMON – fullname: LIDDAMENT MARK TERENCE – fullname: COOKSEY BRIDGET ANN – fullname: DOYLE ANTHONY – fullname: CLARKE ADAM |
| BookMark | eNrjYmDJy89L5WQQcfQL8dT19NE1VQCxnPxdPF2DeRhY0xJzilN5oTQ3g6Kba4izh25qQX58anFBYnJqXmpJvLOfoaGBkZm5pYWZozExagAiSyAb |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | 抗IL-5抗体 |
| ExternalDocumentID | CN110267986A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CN110267986A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Nov 08 04:42:50 EST 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | Chinese English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CN110267986A3 |
| Notes | Application Number: CN20178079923 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190920&DB=EPODOC&CC=CN&NR=110267986A |
| ParticipantIDs | epo_espacenet_CN110267986A |
| PublicationCentury | 2000 |
| PublicationDate | 20190920 |
| PublicationDateYYYYMMDD | 2019-09-20 |
| PublicationDate_xml | – month: 09 year: 2019 text: 20190920 day: 20 |
| PublicationDecade | 2010 |
| PublicationYear | 2019 |
| RelatedCompanies | CEPHALON, INC |
| RelatedCompanies_xml | – name: CEPHALON, INC |
| Score | 3.3430583 |
| Snippet | Disclosed herein are fully human antibody molecules that immunospecifically bind to human IL-5. The antibody molecules can bind to human IL-5 with an... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | ANTI-IL-5 ANTIBODIES |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190920&DB=EPODOC&locale=&CC=CN&NR=110267986A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTdNMjWzNDLXNbJMBo1WpabpWqSZGeommhsmJponpqYYpoHGO3z9zDxCTbwiTCOYGLJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGrR3DKzdLI0M1FycbF0D_F38ndWcnW2d_dT8gmyBtZwRaMLBzJGZgRV07BbonH3XMCfQrpQC5CrFTZCBLQBoWl6JEANTVYYwA6cz7OY1YQYOX-iEN5AJzXvFIgwijn4hnrqePrqmCiCWkz-oJSfKoOjmGuLsoQs0Ph7ul3hnP4RLjMUYWIB9_FQJBgXDZAOLtOQ0Y8Nk0Il4RikWycB61cIcdJkXsAGXkijJIIXbHCl8ktIMXKBwAS1xMDKQYWApKSpNlQXWoyVJcuAAAABgrnMe |
| link.rule.ids | 230,308,780,885,25564,76547 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTdNMjWzNDLXNbJMBo1WpabpWqSZGeommhsmJponpqYYpoHGO3z9zDxCTbwiTCOYGLJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGrR3DKzdLI0M1FycbF0D_F38ndWcnW2d_dT8gmyBtZwRaMLBzJGZgdUcdOMuqOkU5gTalVKAXKW4CTKwBQBNyysRYmCqyhBm4HSG3bwmzMDhC53wBjKhea9YhEHE0S_EU9fTR9dUAcRy8ge15EQZFN1cQ5w9dIHGx8P9Eu_sh3CJsRgDC7CPnyrBoGCYbGCRlpxmbJgMOhHPKMUiGVivWpiDLvMCNuBSEiUZpHCbI4VPUp6B0yPE1yfex9PPW5qBCxRGoOUORgYyDCwlRaWpssA6tSRJDhwYAO50dg8 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTI-IL-5+ANTIBODIES&rft.inventor=LAINE+DAVID+JOSE+SIMON&rft.inventor=LIDDAMENT+MARK+TERENCE&rft.inventor=COOKSEY+BRIDGET+ANN&rft.inventor=DOYLE+ANTHONY&rft.inventor=CLARKE+ADAM&rft.date=2019-09-20&rft.externalDBID=A&rft.externalDocID=CN110267986A |